#adt — Public Fediverse posts

Aptivi Development Toolkit (ADT) has a new logo!

#Aptivi #ADT #Python #csharp #programming #dotnet #TechNews #TechUpdates

https://officialaptivi.wordpress.com/2026/05/11/aptivi-development-toolkit-adt-branding-logo-revealed/

Aptivi Development Toolkit (ADT) has a new logo!

#Aptivi #ADT #Python #csharp #programming #dotnet #TechNews #TechUpdates

https://officialaptivi.wordpress.com/2026/05/11/aptivi-development-toolkit-adt-branding-logo-revealed/

Aptivi Development Toolkit (ADT) has a new logo!

#Aptivi #ADT #Python #csharp #programming #dotnet #TechNews #TechUpdates

https://officialaptivi.wordpress.com/2026/05/11/aptivi-development-toolkit-adt-branding-logo-revealed/

Aptivi Development Toolkit (ADT) has a new logo!

#Aptivi #ADT #Python #csharp #programming #dotnet #TechNews #TechUpdates

https://officialaptivi.wordpress.com/2026/05/11/aptivi-development-toolkit-adt-branding-logo-revealed/

Aptivi Development Toolkit (ADT) has a new logo!

#Aptivi #ADT #Python #csharp #programming #dotnet #TechNews #TechUpdates

https://officialaptivi.wordpress.com/2026/05/11/aptivi-development-toolkit-adt-branding-logo-revealed/

Aptivi Development Toolkit (ADT) branding logo revealed!

Since the first release of Aptivi Development Toolkit (ADT) on March 2026, the toolkit has seen numerous improvements, including the addition of custom hooks and other features. With the release of version 1.1.0.0 that added custom hooks, we’re so excited to set a bright future for this toolkit.

This toolkit not only simplifies the build process, but also streamlines project management, such as cleaning binaries, pushing binaries to repositories, and so on, with custom vendor scripts as the medium to increase the range of projects that can use ADT. It also works with GitHub Actions and other CI solutions, not just on your local machine, to ensure that your projects build successfully on such environments, both online and offline.

We are so excited to reveal the new logo of ADT, which you can now see below!

This new logo is available in the updated branding kit, which you can download here.

Learn more about this new logo here.

Aptivi Development Toolkit (ADT) branding logo revealed!

Since the first release of Aptivi Development Toolkit (ADT) on March 2026, the toolkit has seen numerous improvements, including the addition of custom hooks and other features. With the release of version 1.1.0.0 that added custom hooks, we’re so excited to set a bright future for this toolkit.

This toolkit not only simplifies the build process, but also streamlines project management, such as cleaning binaries, pushing binaries to repositories, and so on, with custom vendor scripts as the medium to increase the range of projects that can use ADT. It also works with GitHub Actions and other CI solutions, not just on your local machine, to ensure that your projects build successfully on such environments, both online and offline.

We are so excited to reveal the new logo of ADT, which you can now see below!

This new logo is available in the updated branding kit, which you can download here.

Learn more about this new logo here.

Aptivi Development Toolkit (ADT) branding logo revealed!

Since the first release of Aptivi Development Toolkit (ADT) on March 2026, the toolkit has seen numerous improvements, including the addition of custom hooks and other features. With the release of version 1.1.0.0 that added custom hooks, we’re so excited to set a bright future for this toolkit.

This toolkit not only simplifies the build process, but also streamlines project management, such as cleaning binaries, pushing binaries to repositories, and so on, with custom vendor scripts as the medium to increase the range of projects that can use ADT. It also works with GitHub Actions and other CI solutions, not just on your local machine, to ensure that your projects build successfully on such environments, both online and offline.

We are so excited to reveal the new logo of ADT, which you can now see below!

This new logo is available in the updated branding kit, which you can download here.

Learn more about this new logo here.

Aptivi Development Toolkit (ADT) branding logo revealed!

Since the first release of Aptivi Development Toolkit (ADT) on March 2026, the toolkit has seen numerous improvements, including the addition of custom hooks and other features. With the release of version 1.1.0.0 that added custom hooks, we’re so excited to set a bright future for this toolkit.

This toolkit not only simplifies the build process, but also streamlines project management, such as cleaning binaries, pushing binaries to repositories, and so on, with custom vendor scripts as the medium to increase the range of projects that can use ADT. It also works with GitHub Actions and other CI solutions, not just on your local machine, to ensure that your projects build successfully on such environments, both online and offline.

We are so excited to reveal the new logo of ADT, which you can now see below!

This new logo is available in the updated branding kit, which you can download here.

Learn more about this new logo here.

Aptivi Development Toolkit (ADT) branding logo revealed!

Since the first release of Aptivi Development Toolkit (ADT) on March 2026, the toolkit has seen numerous improvements, including the addition of custom hooks and other features. With the release of version 1.1.0.0 that added custom hooks, we’re so excited to set a bright future for this toolkit.

This toolkit not only simplifies the build process, but also streamlines project management, such as cleaning binaries, pushing binaries to repositories, and so on, with custom vendor scripts as the medium to increase the range of projects that can use ADT. It also works with GitHub Actions and other CI solutions, not just on your local machine, to ensure that your projects build successfully on such environments, both online and offline.

We are so excited to reveal the new logo of ADT, which you can now see below!

This new logo is available in the updated branding kit, which you can download here.

Learn more about this new logo here.

Aptivi Development Toolkit v1.1.0.0 is now available!

#Aptivi #ADT #TechNews #TechUpdates #csharp #programming #dotnet #python

https://officialaptivi.wordpress.com/2026/05/10/aptivi-development-toolkit-v1-1-is-now-available/

Aptivi Development Toolkit v1.1 is now available!

Earlier this year, we’ve released the first version of Aptivi Development Toolkit (ADT) after months of planning and execution, with the older platform-specific scripts as the medium for our plans. This version was made for developers to integrate the toolkit to their projects to make the build system more predictable and consistent across platforms. This toolkit also provided some basic Git operations, such as creating commits and pushing them.

Since the initial March release, we’ve worked towards improving the toolkit by adding features while focusing on improvements that made the toolkit more reliable. Now, we are excited to announce a new version of ADT, which is version v1.1.0.0!

This version of ADT adds two new features, as well as several improvements being made to the toolkit to increase its reliability while preserving usability. The following changes were made since the release of v1.0.2.0:

• Added custom actions
• Added listing remote branches
• Attribute and type validation is now enforced
• Push progress is now clearer
• Fixed submodule changes causing git push fails

This version of the development toolkit will be rolled out to all our projects soon.

To learn more about this version of ADT, as well as the upgrade process in your project, please consult the Newsroom here.

Aptivi Development Toolkit v1.1 is now available!

Earlier this year, we’ve released the first version of Aptivi Development Toolkit (ADT) after months of planning and execution, with the older platform-specific scripts as the medium for our plans. This version was made for developers to integrate the toolkit to their projects to make the build system more predictable and consistent across platforms. This toolkit also provided some basic Git operations, such as creating commits and pushing them.

Since the initial March release, we’ve worked towards improving the toolkit by adding features while focusing on improvements that made the toolkit more reliable. Now, we are excited to announce a new version of ADT, which is version v1.1.0.0!

This version of ADT adds two new features, as well as several improvements being made to the toolkit to increase its reliability while preserving usability. The following changes were made since the release of v1.0.2.0:

• Added custom actions
• Added listing remote branches
• Attribute and type validation is now enforced
• Push progress is now clearer
• Fixed submodule changes causing git push fails

This version of the development toolkit will be rolled out to all our projects soon.

To learn more about this version of ADT, as well as the upgrade process in your project, please consult the Newsroom here.

Aptivi Development Toolkit v1.1 is now available!

Earlier this year, we’ve released the first version of Aptivi Development Toolkit (ADT) after months of planning and execution, with the older platform-specific scripts as the medium for our plans. This version was made for developers to integrate the toolkit to their projects to make the build system more predictable and consistent across platforms. This toolkit also provided some basic Git operations, such as creating commits and pushing them.

Since the initial March release, we’ve worked towards improving the toolkit by adding features while focusing on improvements that made the toolkit more reliable. Now, we are excited to announce a new version of ADT, which is version v1.1.0.0!

This version of ADT adds two new features, as well as several improvements being made to the toolkit to increase its reliability while preserving usability. The following changes were made since the release of v1.0.2.0:

• Added custom actions
• Added listing remote branches
• Attribute and type validation is now enforced
• Push progress is now clearer
• Fixed submodule changes causing git push fails

This version of the development toolkit will be rolled out to all our projects soon.

To learn more about this version of ADT, as well as the upgrade process in your project, please consult the Newsroom here.

Aptivi Development Toolkit v1.1 is now available!

Earlier this year, we’ve released the first version of Aptivi Development Toolkit (ADT) after months of planning and execution, with the older platform-specific scripts as the medium for our plans. This version was made for developers to integrate the toolkit to their projects to make the build system more predictable and consistent across platforms. This toolkit also provided some basic Git operations, such as creating commits and pushing them.

Since the initial March release, we’ve worked towards improving the toolkit by adding features while focusing on improvements that made the toolkit more reliable. Now, we are excited to announce a new version of ADT, which is version v1.1.0.0!

This version of ADT adds two new features, as well as several improvements being made to the toolkit to increase its reliability while preserving usability. The following changes were made since the release of v1.0.2.0:

• Added custom actions
• Added listing remote branches
• Attribute and type validation is now enforced
• Push progress is now clearer
• Fixed submodule changes causing git push fails

This version of the development toolkit will be rolled out to all our projects soon.

To learn more about this version of ADT, as well as the upgrade process in your project, please consult the Newsroom here.

Aptivi Development Toolkit v1.1 is now available!

Earlier this year, we’ve released the first version of Aptivi Development Toolkit (ADT) after months of planning and execution, with the older platform-specific scripts as the medium for our plans. This version was made for developers to integrate the toolkit to their projects to make the build system more predictable and consistent across platforms. This toolkit also provided some basic Git operations, such as creating commits and pushing them.

Since the initial March release, we’ve worked towards improving the toolkit by adding features while focusing on improvements that made the toolkit more reliable. Now, we are excited to announce a new version of ADT, which is version v1.1.0.0!

This version of ADT adds two new features, as well as several improvements being made to the toolkit to increase its reliability while preserving usability. The following changes were made since the release of v1.0.2.0:

• Added custom actions
• Added listing remote branches
• Attribute and type validation is now enforced
• Push progress is now clearer
• Fixed submodule changes causing git push fails

This version of the development toolkit will be rolled out to all our projects soon.

To learn more about this version of ADT, as well as the upgrade process in your project, please consult the Newsroom here.

#hackers of #Canvas login portals for 15,000 institutions, including top universities like Harvard and Oxford, has exfiltrated 3.65 terabytes of student and faculty data in their boldest attempt at monetizing stolen data since announcing itself as #ShinyHunters in 2020.

This massive black hat #BigEdu data security attack runs alongside concurrent supply chain grift attacks on corporate players like #Vimeo #WynnResorts #Snowflake and #Zara, exposing critical flaws in #EdTech & #Corporate #InfoSec partcularly protocol for third-party vendor trust.

The nefarious #ShinyHunters cabal has infiltrated over 400+ organizations in #SAAS & #DRM data breaches including #Google #Salesforce #Workday, #Crunchbase, #Gucci, #Coinbase, and #Qantas airlines not to mention so called "Security" professionals such as #CrowdStrike and #ADT

https://www.pcmag.com/news/video-platform-vimeo-hacked-by-shinyhunters-gang

https://www.docontrol.io/blog/shinyhunters

https://www.securityweek.com/wynn-resorts-says-21000-employees-affected-by-shinyhunters-hack/

https://www.reco.ai/blog/shinyhunters-data-breach-vs-saas-why-dynamic-security-matters

#hackers of #Canvas login portals for 15,000 institutions, including top universities like Harvard and Oxford, has exfiltrated 3.65 terabytes of student and faculty data in their boldest attempt at monetizing stolen data since announcing itself as #ShinyHunters in 2020.

This massive black hat #BigEdu data security attack runs alongside concurrent supply chain grift attacks on corporate players like #Vimeo #WynnResorts #Snowflake and #Zara, exposing critical flaws in #EdTech & #Corporate #InfoSec partcularly protocol for third-party vendor trust.

The nefarious #ShinyHunters cabal has infiltrated over 400+ organizations in #SAAS & #DRM data breaches including #Google #Salesforce #Workday, #Crunchbase, #Gucci, #Coinbase, and #Qantas airlines not to mention so called "Security" professionals such as #CrowdStrike and #ADT

https://www.pcmag.com/news/video-platform-vimeo-hacked-by-shinyhunters-gang

https://www.docontrol.io/blog/shinyhunters

https://www.securityweek.com/wynn-resorts-says-21000-employees-affected-by-shinyhunters-hack/

https://www.reco.ai/blog/shinyhunters-data-breach-vs-saas-why-dynamic-security-matters

#hackers of #Canvas login portals for 15,000 institutions, including top universities like Harvard and Oxford, has exfiltrated 3.65 terabytes of student and faculty data in their boldest attempt at monetizing stolen data since announcing itself as #ShinyHunters in 2020.

This massive black hat #BigEdu data security attack runs alongside concurrent supply chain grift attacks on corporate players like #Vimeo #WynnResorts #Snowflake and #Zara, exposing critical flaws in #EdTech & #Corporate #InfoSec partcularly protocol for third-party vendor trust.

The nefarious #ShinyHunters cabal has infiltrated over 400+ organizations in #SAAS & #DRM data breaches including #Google #Salesforce #Workday, #Crunchbase, #Gucci, #Coinbase, and #Qantas airlines not to mention so called "Security" professionals such as #CrowdStrike and #ADT

https://www.pcmag.com/news/video-platform-vimeo-hacked-by-shinyhunters-gang

https://www.docontrol.io/blog/shinyhunters

https://www.securityweek.com/wynn-resorts-says-21000-employees-affected-by-shinyhunters-hack/

https://www.reco.ai/blog/shinyhunters-data-breach-vs-saas-why-dynamic-security-matters

Brecha de Datos en ADT y sus Imp…

La reciente brecha de datos en ADT, reportada el lunes, implica que cibercriminales accedieron a un conjunto limitado de información de clientes y prospectos. Este incidente subraya las vulnerabilidades en sistemas de seguridad que se consideran robustos.

https://norvik.tech/news/analisis-ciberseguridad-adt-breach-2023

#Technology #Ciberseguridad #BrechaDeDatos #Adt #ProteccionDeDatos #NorvikTech #DesarrolloSoftware #TechInnovation

Brecha de Datos en ADT y sus Imp…

La reciente brecha de datos en ADT, reportada el lunes, implica que cibercriminales accedieron a un conjunto limitado de información de clientes y prospectos. Este incidente subraya las vulnerabilidades en sistemas de seguridad que se consideran robustos.

https://norvik.tech/news/analisis-ciberseguridad-adt-breach-2023

#Technology #Ciberseguridad #BrechaDeDatos #Adt #ProteccionDeDatos #NorvikTech #DesarrolloSoftware #TechInnovation

Brecha de Datos en ADT y sus Imp…

La reciente brecha de datos en ADT, reportada el lunes, implica que cibercriminales accedieron a un conjunto limitado de información de clientes y prospectos. Este incidente subraya las vulnerabilidades en sistemas de seguridad que se consideran robustos.

https://norvik.tech/news/analisis-ciberseguridad-adt-breach-2023

#Technology #Ciberseguridad #BrechaDeDatos #Adt #ProteccionDeDatos #NorvikTech #DesarrolloSoftware #TechInnovation

Brecha de Datos en ADT y sus Imp…

La reciente brecha de datos en ADT, reportada el lunes, implica que cibercriminales accedieron a un conjunto limitado de información de clientes y prospectos. Este incidente subraya las vulnerabilidades en sistemas de seguridad que se consideran robustos.

https://norvik.tech/news/analisis-ciberseguridad-adt-breach-2023

#Technology #Ciberseguridad #BrechaDeDatos #Adt #ProteccionDeDatos #NorvikTech #DesarrolloSoftware #TechInnovation

Home #security giant #ADT #DataBreach affects 5.5 million people

https://www.bleepingcomputer.com/news/security/home-security-giant-adt-data-breach-affects-55-million-people/

#cybersecurity #privacy

Bleeping Computer: Home security giant ADT data breach affects 5.5 million people. “The ShinyHunters extortion group stole the personal information of 5.5 million individuals after breaching the systems of home security giant ADT earlier this month, according to data breach notification service Have I Been Pwned.”

ShinyHunters Breach Exposes 5.5M ADT Customers' Data

A massive data breach at ADT has exposed the sensitive information of 5.5 million customers, including names, addresses, phone numbers, and email addresses, which is now being tracked by breach-tracking service Have I Been Pwned. This incident highlights the importance of staying vigilant about your personal data security.

https://osintsights.com/shinyhunters-breach-exposes-55m-adt-customers-data?utm_source=mastodon&utm_medium=social

#Shinyhunters #DataBreach #CustomerData #Adt #HaveIBeenPwned

#ADT confirms #DataBreach after #ShinyHunters leak threat

https://www.bleepingcomputer.com/news/security/adt-confirms-data-breach-after-shinyhunters-leak-threat/

#cybersecurity #privacy

Aptivi Development Toolkit (ADT) v1.0.2.0 is now available!

Since the first release of Aptivi Development Toolkit (ADT), we have worked on making plans for this toolkit’s updates to make sure that it stays reliable and stable. The first version was first released on March 5th to replace the older shell scripts that formed a toolkit.

We are so excited to announce that the new minor version of ADT, v1.0.2.0, is now available to the public as of today! This version of ADT provides two new features and an improvement across different areas of the toolkit.

Here is the simplified list of the changes that were made to the development toolkit since the initial release:

• Improved project handling
• Help now shows for non-standalone actions when requested with -h

To learn more about this release, along with instructions on how to upgrade ADT to v1.0.2.0, consult the below Newsroom article.

Aptivi Development Toolkit (ADT) v1.0.2.0 is now available!

Since the first release of Aptivi Development Toolkit (ADT), we have worked on making plans for this toolkit’s updates to make sure that it stays reliable and stable. The first version was first released on March 5th to replace the older shell scripts that formed a toolkit.

We are so excited to announce that the new minor version of ADT, v1.0.2.0, is now available to the public as of today! This version of ADT provides two new features and an improvement across different areas of the toolkit.

Here is the simplified list of the changes that were made to the development toolkit since the initial release:

• Improved project handling
• Help now shows for non-standalone actions when requested with -h

To learn more about this release, along with instructions on how to upgrade ADT to v1.0.2.0, consult the below Newsroom article.

Aptivi Development Toolkit (ADT) v1.0.2.0 is now available!

Since the first release of Aptivi Development Toolkit (ADT), we have worked on making plans for this toolkit’s updates to make sure that it stays reliable and stable. The first version was first released on March 5th to replace the older shell scripts that formed a toolkit.

We are so excited to announce that the new minor version of ADT, v1.0.2.0, is now available to the public as of today! This version of ADT provides two new features and an improvement across different areas of the toolkit.

Here is the simplified list of the changes that were made to the development toolkit since the initial release:

• Improved project handling
• Help now shows for non-standalone actions when requested with -h

To learn more about this release, along with instructions on how to upgrade ADT to v1.0.2.0, consult the below Newsroom article.

Aptivi Development Toolkit (ADT) v1.0.2.0 is now available!

Since the first release of Aptivi Development Toolkit (ADT), we have worked on making plans for this toolkit’s updates to make sure that it stays reliable and stable. The first version was first released on March 5th to replace the older shell scripts that formed a toolkit.

We are so excited to announce that the new minor version of ADT, v1.0.2.0, is now available to the public as of today! This version of ADT provides two new features and an improvement across different areas of the toolkit.

Here is the simplified list of the changes that were made to the development toolkit since the initial release:

• Improved project handling
• Help now shows for non-standalone actions when requested with -h

To learn more about this release, along with instructions on how to upgrade ADT to v1.0.2.0, consult the below Newsroom article.

Aptivi Development Toolkit (ADT) v1.0.2.0 is now available!

Since the first release of Aptivi Development Toolkit (ADT), we have worked on making plans for this toolkit’s updates to make sure that it stays reliable and stable. The first version was first released on March 5th to replace the older shell scripts that formed a toolkit.

We are so excited to announce that the new minor version of ADT, v1.0.2.0, is now available to the public as of today! This version of ADT provides two new features and an improvement across different areas of the toolkit.

Here is the simplified list of the changes that were made to the development toolkit since the initial release:

• Improved project handling
• Help now shows for non-standalone actions when requested with -h

To learn more about this release, along with instructions on how to upgrade ADT to v1.0.2.0, consult the below Newsroom article.

Aptivi Development Toolkit (ADT) version 1.0.1.0, the first upgrade for this toolkit, is now available!

#Aptivi #ADT #programming #TechNews #TechUpdates #python #python3

https://officialaptivi.wordpress.com/2026/04/15/aptivi-development-toolkit-adt-v1-0-1-0-is-now-available/

Aptivi Development Toolkit (ADT) version 1.0.1.0, the first upgrade for this toolkit, is now available!

#Aptivi #ADT #programming #TechNews #TechUpdates #python #python3

https://officialaptivi.wordpress.com/2026/04/15/aptivi-development-toolkit-adt-v1-0-1-0-is-now-available/

Aptivi Development Toolkit (ADT) version 1.0.1.0, the first upgrade for this toolkit, is now available!

#Aptivi #ADT #programming #TechNews #TechUpdates #python #python3

https://officialaptivi.wordpress.com/2026/04/15/aptivi-development-toolkit-adt-v1-0-1-0-is-now-available/

Aptivi Development Toolkit (ADT) version 1.0.1.0, the first upgrade for this toolkit, is now available!

#Aptivi #ADT #programming #TechNews #TechUpdates #python #python3

https://officialaptivi.wordpress.com/2026/04/15/aptivi-development-toolkit-adt-v1-0-1-0-is-now-available/

Aptivi Development Toolkit (ADT) version 1.0.1.0, the first upgrade for this toolkit, is now available!

#Aptivi #ADT #programming #TechNews #TechUpdates #python #python3

https://officialaptivi.wordpress.com/2026/04/15/aptivi-development-toolkit-adt-v1-0-1-0-is-now-available/

Aptivi Development Toolkit (ADT) v1.0.1.0 is now available!

Since the first release of Aptivi Development Toolkit (ADT), we have worked on making plans for this toolkit’s updates to make sure that it stays reliable and stable. The first version was first released on March 5th to replace the older shell scripts that formed a toolkit.

We are so excited to announce that the new minor version of ADT, v1.0.1.0, is now available to the public as of today! This version of ADT provides two new features and an improvement across different areas of the toolkit.

Here is the simplified list of the changes that were made to the development toolkit since the initial release:

• Added -d or --dry options for creating commits
• Added --self global parameter
• Improved push output on completion

To learn more about this release, along with instructions on how to upgrade ADT to v1.0.1.0, consult the below Newsroom article.

Aptivi Development Toolkit (ADT) v1.0.1.0 is now available!

Since the first release of Aptivi Development Toolkit (ADT), we have worked on making plans for this toolkit’s updates to make sure that it stays reliable and stable. The first version was first released on March 5th to replace the older shell scripts that formed a toolkit.

We are so excited to announce that the new minor version of ADT, v1.0.1.0, is now available to the public as of today! This version of ADT provides two new features and an improvement across different areas of the toolkit.

Here is the simplified list of the changes that were made to the development toolkit since the initial release:

• Added -d or --dry options for creating commits
• Added --self global parameter
• Improved push output on completion

To learn more about this release, along with instructions on how to upgrade ADT to v1.0.1.0, consult the below Newsroom article.

Aptivi Development Toolkit (ADT) v1.0.1.0 is now available!

Since the first release of Aptivi Development Toolkit (ADT), we have worked on making plans for this toolkit’s updates to make sure that it stays reliable and stable. The first version was first released on March 5th to replace the older shell scripts that formed a toolkit.

We are so excited to announce that the new minor version of ADT, v1.0.1.0, is now available to the public as of today! This version of ADT provides two new features and an improvement across different areas of the toolkit.

Here is the simplified list of the changes that were made to the development toolkit since the initial release:

• Added -d or --dry options for creating commits
• Added --self global parameter
• Improved push output on completion

To learn more about this release, along with instructions on how to upgrade ADT to v1.0.1.0, consult the below Newsroom article.

Aptivi Development Toolkit (ADT) v1.0.1.0 is now available!

Since the first release of Aptivi Development Toolkit (ADT), we have worked on making plans for this toolkit’s updates to make sure that it stays reliable and stable. The first version was first released on March 5th to replace the older shell scripts that formed a toolkit.

We are so excited to announce that the new minor version of ADT, v1.0.1.0, is now available to the public as of today! This version of ADT provides two new features and an improvement across different areas of the toolkit.

Here is the simplified list of the changes that were made to the development toolkit since the initial release:

• Added -d or --dry options for creating commits
• Added --self global parameter
• Improved push output on completion

To learn more about this release, along with instructions on how to upgrade ADT to v1.0.1.0, consult the below Newsroom article.

Aptivi Development Toolkit (ADT) v1.0.1.0 is now available!

Since the first release of Aptivi Development Toolkit (ADT), we have worked on making plans for this toolkit’s updates to make sure that it stays reliable and stable. The first version was first released on March 5th to replace the older shell scripts that formed a toolkit.

We are so excited to announce that the new minor version of ADT, v1.0.1.0, is now available to the public as of today! This version of ADT provides two new features and an improvement across different areas of the toolkit.

Here is the simplified list of the changes that were made to the development toolkit since the initial release:

• Added -d or --dry options for creating commits
• Added --self global parameter
• Improved push output on completion

To learn more about this release, along with instructions on how to upgrade ADT to v1.0.1.0, consult the below Newsroom article.

ADT adds glowing Live Light yard sign and My Safety mobile protection to the ADT+ platform

https://fed.brid.gy/r/https://nerds.xyz/2026/04/adt-live-light/

C'est pas techniquement un papier lié à la santé trans mais c'est pertinent ; sont sortis de nouveaux résultats des cohortes PATCH et STAMPEDE-1 sur l'utilisation de l'estradiol en patch dans le cancer de la prostate[1].

L'utilisation des oestro dans le cancer de la prostate c'est pas nouveau, ça se fait depuis les années 1960, mais ça avait été assez largement abandonné notamment à cause du risque cardiovasculaire (en même temps quand on utilise du DES oui c'est sûr 😬) et de l'arrivée des analogues de la GnRH, plus sûrs. (Au passage oui ça veut dire qu'à un moment dans l'histoire, l'alternative établie à l'orchidectomie/la "castration chimique" c'était des oestro, et pas que des anti-androgènes. Et maintenant t'as des médecins qui essaient de t'expliquer que la monothérapie ça marche pas, 🤦)
Relativement récemment il y a un regain d'intérêt pour l'utilisation de l'estradiol, mais plutôt par voie transdermique (en patch), car bien moins risqué d'un point de vue thromboembolique et pouvant apporter des bénéfices niveau qualité de vie (la thérapie de déprivation androgénique pendant des années, c'est souvent mal vécu par les patients) et niveau risque fracturaire.

Bref, là on a des résultats assez solides qui montrent une non-infériorité des patchs d'estradiol aux analogues de la GnRH (médicaments type décapeptyl) dans le cancer de la prostate (avancé localement) dans la survie sans métastase à 3 ans (et dans la survie globale à 5 ans).
C'est cool pour les personnes qui ont un cancer de la prostate qui pourront s'en servir pour advocate auprès de leurs médecins pour ce traitement si ça les intéresse (cf https://estradiolinitiative.org/).

C'est aussi intéressant pour les personnes transféminines parce que ça prouve encore fois l'efficacité de la monothérapie, et parce que ça continue à montrer la bonne sécurité cardiovasculaire/thromboembolique de l'estradiol à relative haute dose (300-400µg/j en patch, taux d'estradiol dans les 250 pg/mL).
Précédemment on avait cette analyse[2] des résultats de l'étude PATCH qui va un peu plus dans les détails sur le sujet qui trouve pas plus de mortalité ou de morbidité cardiovasculaire chez les personnes sous oestro.
(Ce qui à mon avis s'ajoute aux diverses preuves que le surrisque cardiovasculaire et thromboembolique chez les personnes transfem ce n'est pas entièrement ni même principalement un fait du THS, mais c'est plutôt lié aux conditions socio-économiques défavorables et au stress minoritaire).

[1] : Transdermal Estradiol Patches in Locally Advanced Prostate Cancer. Langley RE et al., 2026. https://doi.org/10.1056%2FNEJMoa2511781

[2] : Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. Langley RE et al., 2021. https://doi.org/10.1016/S0140-6736(21)00100-8

#prostatecancer #e2 #estradiol #ADT #VTE #cardiovascular #monotherapy

C'est pas techniquement un papier lié à la santé trans mais c'est pertinent ; sont sortis de nouveaux résultats des cohortes PATCH et STAMPEDE-1 sur l'utilisation de l'estradiol en patch dans le cancer de la prostate[1].

L'utilisation des oestro dans le cancer de la prostate c'est pas nouveau, ça se fait depuis les années 1960, mais ça avait été assez largement abandonné notamment à cause du risque cardiovasculaire (en même temps quand on utilise du DES oui c'est sûr 😬) et de l'arrivée des analogues de la GnRH, plus sûrs. (Au passage oui ça veut dire qu'à un moment dans l'histoire, l'alternative établie à l'orchidectomie/la "castration chimique" c'était des oestro, et pas que des anti-androgènes. Et maintenant t'as des médecins qui essaient de t'expliquer que la monothérapie ça marche pas, 🤦)
Relativement récemment il y a un regain d'intérêt pour l'utilisation de l'estradiol, mais plutôt par voie transdermique (en patch), car bien moins risqué d'un point de vue thromboembolique et pouvant apporter des bénéfices niveau qualité de vie (la thérapie de déprivation androgénique pendant des années, c'est souvent mal vécu par les patients) et niveau risque fracturaire.

Bref, là on a des résultats assez solides qui montrent une non-infériorité des patchs d'estradiol aux analogues de la GnRH (médicaments type décapeptyl) dans le cancer de la prostate (avancé localement) dans la survie sans métastase à 3 ans (et dans la survie globale à 5 ans).
C'est cool pour les personnes qui ont un cancer de la prostate qui pourront s'en servir pour advocate auprès de leurs médecins pour ce traitement si ça les intéresse (cf https://estradiolinitiative.org/).

C'est aussi intéressant pour les personnes transféminines parce que ça prouve encore fois l'efficacité de la monothérapie, et parce que ça continue à montrer la bonne sécurité cardiovasculaire/thromboembolique de l'estradiol à relative haute dose (300-400µg/j en patch, taux d'estradiol dans les 250 pg/mL).
Précédemment on avait cette analyse[2] des résultats de l'étude PATCH qui va un peu plus dans les détails sur le sujet qui trouve pas plus de mortalité ou de morbidité cardiovasculaire chez les personnes sous oestro.
(Ce qui à mon avis s'ajoute aux diverses preuves que le surrisque cardiovasculaire et thromboembolique chez les personnes transfem ce n'est pas entièrement ni même principalement un fait du THS, mais c'est plutôt lié aux conditions socio-économiques défavorables et au stress minoritaire).

[1] : Transdermal Estradiol Patches in Locally Advanced Prostate Cancer. Langley RE et al., 2026. https://doi.org/10.1056%2FNEJMoa2511781

[2] : Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. Langley RE et al., 2021. https://doi.org/10.1016/S0140-6736(21)00100-8

#prostatecancer #e2 #estradiol #ADT #VTE #cardiovascular #monotherapy

C'est pas techniquement un papier lié à la santé trans mais c'est pertinent ; sont sortis de nouveaux résultats des cohortes PATCH et STAMPEDE-1 sur l'utilisation de l'estradiol en patch dans le cancer de la prostate[1].

L'utilisation des oestro dans le cancer de la prostate c'est pas nouveau, ça se fait depuis les années 1960, mais ça avait été assez largement abandonné notamment à cause du risque cardiovasculaire (en même temps que on utilise du DES oui c'est sûr 😬) et de l'arrivée des analogues de la GnRH, plus sûrs. (Au passage oui ça veut dire qu'à un moment dans l'histoire, l'alternative établie à l'orchidectomie/la "castration chimique" c'était des oestro, et pas que des anti-androgènes. Et maintenant t'as des médecins qui essaient de t'expliquer que la monothérapie ça marche pas, 🤦)
Relativement récemment y'a un regain d'intérêt pour l'utilisation de l'estradiol, mais plutôt par voie transdermique (en patch), psk bien moins risqué d'un point de vue thromboembolique, et psk peut apporter des bénéfices niveau qualité de vie (la thérapie de déprivation androgénique/ADT pendant des années, c'est souvent mal vécu par les patients! + niveau risque fracturaire).

Bref, là on a des résultats assez solides qui montrent une non-infériorité des patchs d'estradiol aux analogues de la GnRH (médicaments type décapeptyl) dans le cancer de la prostate (avancé localement) dans la survie sans métastase à 3 ans (et dans la survie globale à 5 ans).
C'est cool pour les personnes qui ont un cancer de la prostate qui pourront s'en servir pour advocate auprès de leurs médecins pour ce traitement si ça les intéresse (cf https://estradiolinitiative.org/).

C'est aussi intéressant pour les personnes transféminines parce que ça prouve encore fois l'efficacité de la monothérapie, et parce que ça continue à montrer la bonne sécurité cardiovasculaire/thromboembolique de l'estradiol à relative haute dose (300-400µg/j en patch, taux d'estradiol dans les 250 pg/mL).
Précédemment on avait cette analyse[2] des résultats de l'étude PATCH qui va un peu plus dans les détails sur le sujet qui trouve pas plus de mortalité ou de morbidité cardiovasculaire chez les personnes sous oestro.
(Ce qui à mon avis s'ajoute aux diverses preuves que le surrisque cardiovasculaire et thromboembolique chez les personnes transfem ce n'est pas entièrement ni même principalement un fait du THS, mais c'est plutôt lié aux conditions socio-économiques défavorables et au stress minoritaire).

[1] : Transdermal Estradiol Patches in Locally Advanced Prostate Cancer. Langley RE et al., 2026. https://doi.org/10.1056%2FNEJMoa2511781
[2] : Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. Langley RE et al., 2021. https://doi.org/10.1016/S0140-6736(21)00100-8

#prostatecancer #e2 #estradiol #ADT #VTE #cardiovascular

C'est pas techniquement un papier lié à la santé trans mais c'est pertinent ; sont sortis de nouveaux résultats des cohortes PATCH et STAMPEDE-1 sur l'utilisation de l'estradiol en patch dans le cancer de la prostate[1].

L'utilisation des oestro dans le cancer de la prostate c'est pas nouveau, ça se fait depuis les années 1960, mais ça avait été assez largement abandonné notamment à cause du risque cardiovasculaire (en même temps que on utilise du DES oui c'est sûr 😬) et de l'arrivée des analogues de la GnRH, plus sûrs. (Au passage oui ça veut dire qu'à un moment dans l'histoire, l'alternative établie à l'orchidectomie/la "castration chimique" c'était des oestro, et pas que des anti-androgènes. Et maintenant t'as des médecins qui essaient de t'expliquer que la monothérapie ça marche pas, 🤦)
Relativement récemment y'a un regain d'intérêt pour l'utilisation de l'estradiol, mais plutôt par voie transdermique (en patch), psk bien moins risqué d'un point de vue thromboembolique, et psk peut apporter des bénéfices niveau qualité de vie (la thérapie de déprivation androgénique/ADT pendant des années, c'est souvent mal vécu par les patients! + niveau risque fracturaire).

Bref, là on a des résultats assez solides qui montrent une non-infériorité des patchs d'estradiol aux analogues de la GnRH (médicaments type décapeptyl) dans le cancer de la prostate (avancé localement) dans la survie sans métastase à 3 ans (et dans la survie globale à 5 ans).
C'est cool pour les personnes qui ont un cancer de la prostate qui pourront s'en servir pour advocate auprès de leurs médecins pour ce traitement si ça les intéresse (cf https://estradiolinitiative.org/).

C'est aussi intéressant pour les personnes transféminines parce que ça prouve encore fois l'efficacité de la monothérapie, et parce que ça continue à montrer la bonne sécurité cardiovasculaire/thromboembolique de l'estradiol à relative haute dose (300-400µg/j en patch, taux d'estradiol dans les 250 pg/mL).
Précédemment on avait cette analyse[2] des résultats de l'étude PATCH qui va un peu plus dans les détails sur le sujet qui trouve pas plus de mortalité ou de morbidité cardiovasculaire chez les personnes sous oestro.
(Ce qui à mon avis s'ajoute aux diverses preuves que le surrisque cardiovasculaire et thromboembolique chez les personnes transfem ce n'est pas entièrement ni même principalement un fait du THS, mais c'est plutôt lié aux conditions socio-économiques défavorables et au stress minoritaire).

[1] : Transdermal Estradiol Patches in Locally Advanced Prostate Cancer. Langley RE et al., 2026. https://doi.org/10.1056%2FNEJMoa2511781
[2] : Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. Langley RE et al., 2021. https://doi.org/10.1016/S0140-6736(21)00100-8

#prostatecancer #e2 #estradiol #ADT #VTE #cardiovascular

C'est pas techniquement un papier lié à la santé trans mais c'est pertinent ; sont sortis de nouveaux résultats des cohortes PATCH et STAMPEDE-1 sur l'utilisation de l'estradiol en patch dans le cancer de la prostate[1].

L'utilisation des oestro dans le cancer de la prostate c'est pas nouveau, ça se fait depuis les années 1960, mais ça avait été assez largement abandonné notamment à cause du risque cardiovasculaire (en même temps quand on utilise du DES oui c'est sûr 😬) et de l'arrivée des analogues de la GnRH, plus sûrs. (Au passage oui ça veut dire qu'à un moment dans l'histoire, l'alternative établie à l'orchidectomie/la "castration chimique" c'était des oestro, et pas que des anti-androgènes. Et maintenant t'as des médecins qui essaient de t'expliquer que la monothérapie ça marche pas, 🤦)
Relativement récemment il y a un regain d'intérêt pour l'utilisation de l'estradiol, mais plutôt par voie transdermique (en patch), car bien moins risqué d'un point de vue thromboembolique et pouvant apporter des bénéfices niveau qualité de vie (la thérapie de déprivation androgénique pendant des années, c'est souvent mal vécu par les patients) et niveau risque fracturaire.

Bref, là on a des résultats assez solides qui montrent une non-infériorité des patchs d'estradiol aux analogues de la GnRH (médicaments type décapeptyl) dans le cancer de la prostate (avancé localement) dans la survie sans métastase à 3 ans (et dans la survie globale à 5 ans).
C'est cool pour les personnes qui ont un cancer de la prostate qui pourront s'en servir pour advocate auprès de leurs médecins pour ce traitement si ça les intéresse (cf https://estradiolinitiative.org/).

C'est aussi intéressant pour les personnes transféminines parce que ça prouve encore fois l'efficacité de la monothérapie, et parce que ça continue à montrer la bonne sécurité cardiovasculaire/thromboembolique de l'estradiol à relative haute dose (300-400µg/j en patch, taux d'estradiol dans les 250 pg/mL).
Précédemment on avait cette analyse[2] des résultats de l'étude PATCH qui va un peu plus dans les détails sur le sujet qui trouve pas plus de mortalité ou de morbidité cardiovasculaire chez les personnes sous oestro.
(Ce qui à mon avis s'ajoute aux diverses preuves que le surrisque cardiovasculaire et thromboembolique chez les personnes transfem ce n'est pas entièrement ni même principalement un fait du THS, mais c'est plutôt lié aux conditions socio-économiques défavorables et au stress minoritaire).

[1] : Transdermal Estradiol Patches in Locally Advanced Prostate Cancer. Langley RE et al., 2026. https://doi.org/10.1056%2FNEJMoa2511781

[2] : Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. Langley RE et al., 2021. https://doi.org/10.1016/S0140-6736(21)00100-8

#prostatecancer #e2 #estradiol #ADT #VTE #cardiovascular #monotherapy

"Time to take down your smart cameras"

Did you know your home insurance company or your car insurance may very well use your own smart camera data against you? For example, car gets stolen and the video shows you didn't lock it (no flashing lights), so they don't pay?

Don't worry about not understanding some of the tech in the video. You'll get the point.

https://youtu.be/UMIwNiwQewQ

#ring #adt #camera #surveillance #police

Aptivi Development Toolkit (ADT) and modern GitHub Pages deployment workflow rollout for our projects is finished!

#ADT #Aptivi #GitHub #DocFX #dotnet #csharp #programming #TechNews #TechUpdates

https://officialaptivi.wordpress.com/2026/03/18/github-actions-web-deployment-and-adt-rollout-complete/